Post by CPI

NEWS | CPI is a key partner in the University of Liverpool’s newly launched Cystic Fibrosis Innovation Hub.    The hub is part of a new £15 million Translational Innovation Hub Network, funded by LifeArc and Cystic Fibrosis Trust.    Cystic fibrosis (CF) is a life limiting inherited condition that currently has no cure. People living with CF are susceptible to repeated lung infections, which may be difficult to treat and resistant to antibiotics 🫁    Phage therapies have the potential to treat a wide range of lung infections. CPI is excited to work closely with the University of Liverpool to develop this technology and provide an alternative method to treating antibiotic-resistant infections in people with CF.     Learn more ➡️ https://lnkd.in/eZSyQjtt    Clare Trippett Arun Harish Damian Mohammed Sophie Walton Jonathan Jones   #CysticFibrosis | #PhageTherapy | #LungInfections  #LetsInnovateTogether | #Innovation | #Pharma